» Articles » PMID: 28105098

Radioprotective Effects of Pyrroloquinoline Quinone on Parotid Glands in C57BL/6J Mice

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2017 Jan 21
PMID 28105098
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to investigate whether pyrroloquinoline quinine (PQQ) serve a radioprotective role in parotid gland damage induced by total body irradiation (TBI) in C57BL/6J mice. A total of 15 female 8-week-old C57BL/6J mice were randomly assigned into three treatment groups: i) Untreated control (no irradiation); ii) 4 gray (Gy) X-ray irradiation; iii) 4 Gy X-ray irradiation with additional dietary PQQ (4 mg PQQ/kg in normal diet). Each group included five mice. After 4 weeks, all animals were collected for evaluating the phenotype, body weight, pathological and biochemical parameters. The results indicated that PQQ had biological effects on total body phenotype. PQQ could partially rescue TBI-induced damage to parotid glands. In addition, PQQ served radioprotective effects on parotid glands via multiple mechanisms, such as promoting proliferation, inhibiting apoptosis and senescence, upregulating antioxidant ability, scavenging reactive oxygen species and reducing DNA damage. The results of the present study demonstrate that PQQ serves a radioprotective role in parotid gland damage induced by TBI, possibly via inhibiting oxidative stress and participating in DNA damage repair. The study provides experimental and theoretical knowledge for the development of radioprotective clinical drugs.

Citing Articles

Natural Guardians: Natural Compounds as Radioprotectors in Cancer Therapy.

Stasilowicz-Krzemien A, Gosciniak A, Formanowicz D, Cielecka-Piontek J Int J Mol Sci. 2024; 25(13).

PMID: 39000045 PMC: 11241526. DOI: 10.3390/ijms25136937.


Effects of Pyrroloquinoline Quinone on Lipid Metabolism and Anti-Oxidative Capacity in a High-Fat-Diet Metabolic Dysfunction-Associated Fatty Liver Disease Chick Model.

Qiu K, Zhao Q, Wang J, Qi G, Wu S, Zhang H Int J Mol Sci. 2021; 22(3).

PMID: 33535680 PMC: 7867196. DOI: 10.3390/ijms22031458.


Pyrroloquinoline Quinone Prevents Estrogen Deficiency-Induced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence.

Geng Q, Gao H, Yang R, Guo K, Miao D Int J Biol Sci. 2019; 15(1):58-68.

PMID: 30662347 PMC: 6329928. DOI: 10.7150/ijbs.25783.


Effect and mechanism of pyrroloquinoline quinone on anti-osteoporosis in Bmi-1 knockout mice-Anti-oxidant effect of pyrroloquinoline quinone.

Huang Y, Chen N, Miao D Am J Transl Res. 2017; 9(10):4361-4374.

PMID: 29118900 PMC: 5666047.

References
1.
Stites T, Mitchell A, Rucker R . Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr. 2000; 130(4):719-27. DOI: 10.1093/jn/130.4.719. View

2.
Medina V, Prestifilippo J, Croci M, Carabajal E, Bergoc R, Elverdin J . Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation. Int J Radiat Biol. 2010; 87(3):284-92. DOI: 10.3109/09553002.2010.533247. View

3.
Liu H, Guo J, Wang L, Chen N, Karaplis A, Goltzman D . Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. J Endocrinol. 2009; 203(2):203-13. DOI: 10.1677/JOE-09-0247. View

4.
Zhu B, Simonis U, Cecchini G, Zhou H, Li L, Teerlink J . Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 2006; 11(2):119-28. DOI: 10.1177/1074248406288757. View

5.
Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T . Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 1995; 182(2):367-77. PMC: 2192111. DOI: 10.1084/jem.182.2.367. View